Posterior-scleritis: Case report of an uncommon immune-related adverse event in the treatment of advanced endometrial cancer

por Ing, Brandon I., Kuhl, Derek, Glassman, Deanna, Johnson, Cynae A., Patel, Shrina, Jazaeri, Amir A.
Publicado 2023

Targeting CCR2(+) macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer

por Wu, Yutuan, Jennings, Nicholas B., Sun, Yunjie, Dasari, Santosh K., Bayraktar, Emine, Corvigno, Sara, Stur, Elaine, Glassman, Deanna, Mangala, Lingegowda S., Lankenau Ahumada, Adrian, Westin, Shannon N., Sood, Anil K., Hu, Wei
Publicado 2022

Endothelial p130cas confers resistance to anti-angiogenesis therapy

por Wen, Yunfei, Chelariu-Raicu, Anca, Umamaheswaran, Sujanitha, Nick, Alpa M., Stur, Elaine, Hanjra, Pahul, Jiang, Dahai, Jennings, Nicholas B., Chen, Xiuhui, Corvigno, Sara, Glassman, Deanna, Lopez-Berestein, Gabriel, Liu, Jinsong, Hung, Mien-Chie, Sood, Anil K.
Publicado 2023

Endothelial p130cas confers resistance to anti-angiogenesis therapy

por Wen, Yunfei, Chelariu-Raicu, Anca, Umamaheswaran, Sujanitha, Nick, Alpa M., Stur, Elaine, Hanjra, Pahul, Jiang, Dahai, Jennings, Nicholas B., Chen, Xiuhui, Corvigno, Sara, Glassman, Deanna, Lopez-Berestein, Gabriel, Liu, Jinsong, Hung, Mien-Chie, Sood, Anil K.
Publicado 2022

Endothelial p130cas confers resistance to anti-angiogenesis therapy

por Wen, Yunfei, Chelariu-Raicu, Anca, Umamaheswaran, Sujanitha, Nick, Alpa M., Stur, Elaine, Hanjra, Pahul, Jiang, Dahai, Jennings, Nicholas B., Chen, Xiuhui, Corvigno, Sara, Glassman, Deanna, Lopez-Berestein, Gabriel, Liu, Jinsong, Hung, Mien-Chie, Sood, Anil K.
Publicado 2022

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer

por Glassman, Deanna, Bateman, Nicholas W., Lee, Sanghoon, Zhao, Li, Yao, Jun, Tan, Yukun, Ivan, Cristina, Rangel, Kelly M., Zhang, Jianhua, Conrads, Kelly A., Hood, Brian L., Abulez, Tamara, Futreal, P. Andrew, Fleming, Nicole D., Afshar-Kharghan, Vahid, Maxwell, George L., Conrads, Thomas P., Chen, Ken, Sood, Anil K.
Publicado 2022

Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer

por Glassman, Deanna, Kim, Mark S., Spradlin, Meredith, Badal, Sunil, Taki, Mana, Bhattacharya, Pratip, Dutta, Prasanta, Kingsley, Charles V., Foster, Katherine I., Animasahun, Olamide, Jeon, Jin Heon, Achreja, Abhinav, Jayaraman, Anusha, Kumar, Praveen, Nenwani, Minal, Wuchu, Fulei, Bayraktar, Emine, Wu, Yutuan, Stur, Elaine, Mangala, Lingegowda, Lee, Sanghoon, Yap, Timothy A., Westin, Shannon N., Eberlin, Livia S., Nagrath, Deepak, Sood, Anil K.
Publicado 2023

Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics

por Handley, Katelyn F., Sims, Travis T., Bateman, Nicholas W., Glassman, Deanna, Foster, Katherine I., Lee, Sanghoon, Yao, Jun, Yao, Hui, Fellman, Bryan M., Liu, Jinsong, Lu, Zhen, Conrads, Kelly A., Hood, Brian L., Barakat, Waleed, Zhao, Li, Zhang, Jianhua, Westin, Shannon N., Celestino, Joseph, Rangel, Kelly M., Badal, Sunil, Pereira, Igor, Ram, Prahlad T., Maxwell, George L., Eberlin, Livia S., Futreal, P. Andrew, Bast, Robert C., Fleming, Nicole D., Conrads, Thomas P., Sood, Anil K.
Publicado 2022